NO20024679D0 - Krystallinsk farmasöytikum - Google Patents

Krystallinsk farmasöytikum

Info

Publication number
NO20024679D0
NO20024679D0 NO20024679A NO20024679A NO20024679D0 NO 20024679 D0 NO20024679 D0 NO 20024679D0 NO 20024679 A NO20024679 A NO 20024679A NO 20024679 A NO20024679 A NO 20024679A NO 20024679 D0 NO20024679 D0 NO 20024679D0
Authority
NO
Norway
Prior art keywords
pharmaceuticals
crystalline
crystalline pharmaceuticals
lopinavir
disclosed
Prior art date
Application number
NO20024679A
Other languages
English (en)
Other versions
NO325005B1 (no
NO20024679L (no
Inventor
Daniel A Dickman
Sanjay Chemburkar
James J Fort
Rodger F Henry
David Lechuga-Ballesteros
Yuping Niu
William Porter
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27065762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024679(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/793,536 external-priority patent/US6608198B2/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20024679L publication Critical patent/NO20024679L/no
Publication of NO20024679D0 publication Critical patent/NO20024679D0/no
Publication of NO325005B1 publication Critical patent/NO325005B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20024679A 2000-03-30 2002-09-30 Krystallinske former av lopinavir, farmasoytiske sammensetninger omfattende disse og deres anvendelse NO325005B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53825700A 2000-03-30 2000-03-30
US09/793,536 US6608198B2 (en) 2000-03-30 2001-02-27 Crystalline pharmaceutical
PCT/US2001/009112 WO2001074787A2 (en) 2000-03-30 2001-03-21 Crystalline pharmaceutical

Publications (3)

Publication Number Publication Date
NO20024679L NO20024679L (no) 2002-09-30
NO20024679D0 true NO20024679D0 (no) 2002-09-30
NO325005B1 NO325005B1 (no) 2008-01-14

Family

ID=27065762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024679A NO325005B1 (no) 2000-03-30 2002-09-30 Krystallinske former av lopinavir, farmasoytiske sammensetninger omfattende disse og deres anvendelse

Country Status (22)

Country Link
EP (1) EP1268442A2 (no)
JP (1) JP2003529592A (no)
KR (1) KR100773258B1 (no)
CN (2) CN101066952A (no)
AR (2) AR033360A1 (no)
AU (3) AU2001250920B2 (no)
BG (1) BG107165A (no)
BR (1) BR0109433A (no)
CA (1) CA2403635A1 (no)
CZ (1) CZ20023529A3 (no)
HU (1) HUP0302675A3 (no)
IL (1) IL151551A0 (no)
MX (1) MXPA02009559A (no)
MY (1) MY128296A (no)
NO (1) NO325005B1 (no)
NZ (1) NZ521183A (no)
PE (1) PE20011232A1 (no)
PL (1) PL359727A1 (no)
SA (2) SA06270303B1 (no)
SK (1) SK14832002A3 (no)
TW (1) TWI284640B (no)
WO (1) WO2001074787A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608198B2 (en) 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
EP2393786B1 (en) 2009-02-06 2014-01-22 Hetero Research Foundation Novel polymorphs of lopinavir
JP5789260B2 (ja) * 2009-08-27 2015-10-07 メルク・シャープ・エンド・ドーム・コーポレイション Ｃ型肝炎ウイルスのプロテアーゼ阻害薬の調製方法
CN112830899A (zh) * 2021-01-18 2021-05-25 合肥华方医药科技有限公司 一种洛匹那韦新晶型及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
WO1998057648A1 (en) * 1997-06-16 1998-12-23 Vertex Pharmaceuticals Incorporated Methods of increasing the bioavailability of stable crystal polymorphs of a compound

Also Published As

Publication number Publication date
NO325005B1 (no) 2008-01-14
WO2001074787A2 (en) 2001-10-11
PL359727A1 (en) 2004-09-06
CA2403635A1 (en) 2001-10-11
IL151551A0 (en) 2003-04-10
SA01220270B1 (ar) 2006-11-14
KR20030011807A (ko) 2003-02-11
AR049560A2 (es) 2006-08-16
NO20024679L (no) 2002-09-30
CN101066952A (zh) 2007-11-07
CZ20023529A3 (cs) 2003-02-12
EP1268442A2 (en) 2003-01-02
MY128296A (en) 2007-01-31
MXPA02009559A (es) 2003-05-21
KR100773258B1 (ko) 2007-11-05
WO2001074787A3 (en) 2002-02-07
PE20011232A1 (es) 2001-12-08
AU5092001A (en) 2001-10-15
SK14832002A3 (sk) 2003-02-04
BR0109433A (pt) 2004-08-10
CN1330639C (zh) 2007-08-08
TWI284640B (en) 2007-08-01
HUP0302675A3 (en) 2004-03-29
AU2006222711A1 (en) 2006-10-19
HUP0302675A2 (hu) 2003-12-29
NZ521183A (en) 2004-03-26
CN1422259A (zh) 2003-06-04
JP2003529592A (ja) 2003-10-07
SA06270303B1 (ar) 2009-08-02
BG107165A (bg) 2003-07-31
AR033360A1 (es) 2003-12-17
AU2001250920B2 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
EA199900373A2 (ru) Фармацевтические композиции
DOP2001000151A (es) Derivados de imidazopirimidina y derivados de triazolopimidina.
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
SE0000540D0 (sv) New compounds
IT1319645B1 (it) Base cristallina di citalopram.
NO20034439L (no) Benzamidinderivater
NO20043067L (no) Dynamisk tilstedevaerelsesadministrasjon
NO20003968D0 (no) Farmasøytiske preparater
DK1419152T3 (da) HIV-hæmmende pyrimidin-derivater
NO20034044L (no) Metallproteinase-inhibitorer
NL300242I1 (nl) Mega-carboxyaryl gesubstitueerde difenylureums alsraf kinaseremmers.
DE60230216D1 (de) Kaskodenkettenverstärker
NO20044597L (no) Kjemiske forbindelser
NO20034032L (no) Metallproteinase-inhibitorer
NO20033679L (no) Nye pyrimidinforbindelser
SE9901077D0 (sv) Novel use
SE0103710D0 (sv) Compounds
SE9801494D0 (sv) Novel use
BR0007922A (pt) Compostos calcilìticos
DK1331972T3 (da) Farmaceutiske præparater
NO20015892D0 (no) Inhibitorer av metallproteinaser
NO20024679D0 (no) Krystallinsk farmasöytikum
ATE343390T1 (de) Kalzilytische verbindungen
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
IT1320031B1 (it) Disposizione di reti.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application